FindTrial
Sign In

The Safety and Effectiveness of Different Doses of Vitamin C in HIV-Infected Patients

A Dose Escalation Study to Evaluate Tolerance and Antiviral Effect of Oral Vitamin C in Two Groups of HIV-Infected Adults

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00001070
Enrollment
0
Registered
2001-08-31
Start date
Unknown
Completion date
Unknown
Last updated
2023-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV Infections

Brief summary

This is a study to evaluate the tolerance and antiviral effect of oral vitamin C in HIV-infected.

Interventions

DRUGOral Vitamin C

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
Lead SponsorNIH

Study design

Primary purpose
TREATMENT

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Not applicable - Study withdrawn since 04/23/1996

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026